Emma L. Mead

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Assessing Aβ-independent effects of Module 42 on immune function in vitro.

Assessing Aβ-independent effects of Module 42 on immune function in vitro.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: October 01, 2025

Amyloid binding and beyond: a new approach for Alzheimer's disease drug discovery targeting Aβo-PrPC binding and downstream pathways.

Amyloid binding and beyond: a new approach for Alzheimer's disease drug discovery targeting Aβo-PrPC binding and downstream pathways.

Journal: Chemical science

Published: June 24, 2021

PLCγ2 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages.

PLCγ2 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages.

Journal: Scientific reports

Published: April 12, 2021

Selection and structural characterization of anti-TREM2 scFvs that reduce levels of shed ectodomain.

Selection and structural characterization of anti-TREM2 scFvs that reduce levels of shed ectodomain.

Journal: Structure (London, England : 1993)

Published: January 29, 2021

TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation.

TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation.

Journal: Molecular neurodegeneration

Published: November 05, 2020

TREM2 Alzheimer's variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages.

TREM2 Alzheimer's variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages.

Journal: Alzheimer's research & therapy

Published: February 28, 2020

Correction: Interventions for treating children and adolescents with overweight and obesity: an overview of Cochrane reviews.

Correction: Interventions for treating children and adolescents with overweight and obesity: an overview of Cochrane reviews.

Journal: International journal of obesity (2005)

Published: April 04, 2019

Behavior-Changing Interventions for Treating Overweight or Obesity in Children Aged 6 to 11 Years.

Behavior-Changing Interventions for Treating Overweight or Obesity in Children Aged 6 to 11 Years.

Journal: JAMA pediatrics

Published: February 19, 2019

Interventions for treating children and adolescents with overweight and obesity: an overview of Cochrane reviews.

Interventions for treating children and adolescents with overweight and obesity: an overview of Cochrane reviews.

Journal: International journal of obesity (2005)

Published: September 19, 2017

Quality of life in people with vitiligo: a systematic review and meta-analysis.

Quality of life in people with vitiligo: a systematic review and meta-analysis.

Journal: The British journal of dermatology

Published: September 05, 2017

Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years.

Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years.

Journal: The Cochrane database of systematic reviews

Published: June 23, 2017

Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.

Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.

Journal: The Cochrane database of systematic reviews

Published: June 23, 2017

Showing 1-12 of 20

Last Updated: 09/26/2026